Europe’s biotechnology industry is finally beginning to catch up with the US,
according to the international consultancy Ernst & Young. Ken Lee, coauthor
of Ernst & Young’s annual snapshot of the industry, says that the US, with
1287 biotech companies in April 1997, still has the lead, although this figure
represents a drop of 2 per cent on the previous year. But Europe is expanding
rapidly, boasting 716 companies compared to 584 the year before.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
The world's fastest spider tops 3.5 metres per second
2
Where, when and how to watch the 2026 solar eclipse
3
Our verdict on The Selfish Gene: An unpopular piece of popular science
4
Babies are born with the neural foundations for maths
5
We’ve uncovered a master gene that switches on human development
6
I’m the first person whose life was saved by CRISPR base editing
7
The race to understand how and when Thwaites glacier will collapse
8
The best sci-fi novel in 2026 so far – plus 6 other great reads
9
Humans sleep the least of all apes – is it the secret to our success?
10
Europe’s heatwave is the hottest and most humid ever
